Infections/Inflammation/Cystic Disease of the Genitourinary Tract

Jae Duck Choi, Kyong Tae Moon
{"title":"Infections/Inflammation/Cystic Disease of the Genitourinary Tract","authors":"Jae Duck Choi, Kyong Tae Moon","doi":"10.1097/ju.0000000000000927","DOIUrl":null,"url":null,"abstract":"INTRODUCTION AND OBJECTIVE: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) was known to be closely related with erectile dysfunction (ED). However, studies were insufficient and the results are inconsistent. We assessed the relationship between chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and erectile dysfunction (ED) using propensity score matching. METHODS: From 2011 to 2013, data from 8727 male in their 40s and 50s who had participated in a health checkup were analyzed. The National Institutes of Health-Chronic Prostatitis Symptoms Index (NIH-CPSI), International Index of Erectile Function-5 (IIEF), Premature Ejaculation Diagnostic Tool (PEDT), testosterone, basic blood chemistry, and metabolic syndrome (MetS) assessment were used for this study. Symptoms were classified as a ‘no' if respondents reported no perineal or ejaculatory pain or had a NIH-CPSI pain score of <4; the symptoms were classified as ‘moderate to severe' if the pain score was >7 according to a previous study. Of these, 7181 formed the cohort for propensity score matching, including 597 men with moderate to severe prostatitis-like symptom (case) and 6584 men with no prostatitis-like symptom (control), however, ultimately, propensity scores were matched at 1:1 ratio of controls to case group (597 men in control group and 597 men in case group). RESULTS: After propensity score matching, age and PEDT variables which was found to be significantly different before propensity score matching were evenly dispersed and did not differ significantly between the groups (Table 1). After matching, the mean IIEF score of case group was significantly lower than control group (IIEF: 17.2 5.5 vs. 14.7 5.3; P<0.001). Additionally, ED severity was significantly greater in case group (no, mild, mild to moderate, moderate, and severe ED: 27.5%, 30.2%, 24.6%, 13.1%, and 4.7% in control group, 10.7%, 27.0%, 33.0%, 18.9%, and 10.4% in case group; P<0.001). Finally, the rate of moderate to severe ED was significantly higher in case group (17.8% vs. 29.3%; P<0.001). CONCLUSIONS: Presence of moderate to severe prostatitislike symptom was significantly and independently correlated with ED.","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":" 938","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ju.0000000000000927","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION AND OBJECTIVE: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) was known to be closely related with erectile dysfunction (ED). However, studies were insufficient and the results are inconsistent. We assessed the relationship between chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and erectile dysfunction (ED) using propensity score matching. METHODS: From 2011 to 2013, data from 8727 male in their 40s and 50s who had participated in a health checkup were analyzed. The National Institutes of Health-Chronic Prostatitis Symptoms Index (NIH-CPSI), International Index of Erectile Function-5 (IIEF), Premature Ejaculation Diagnostic Tool (PEDT), testosterone, basic blood chemistry, and metabolic syndrome (MetS) assessment were used for this study. Symptoms were classified as a ‘no' if respondents reported no perineal or ejaculatory pain or had a NIH-CPSI pain score of <4; the symptoms were classified as ‘moderate to severe' if the pain score was >7 according to a previous study. Of these, 7181 formed the cohort for propensity score matching, including 597 men with moderate to severe prostatitis-like symptom (case) and 6584 men with no prostatitis-like symptom (control), however, ultimately, propensity scores were matched at 1:1 ratio of controls to case group (597 men in control group and 597 men in case group). RESULTS: After propensity score matching, age and PEDT variables which was found to be significantly different before propensity score matching were evenly dispersed and did not differ significantly between the groups (Table 1). After matching, the mean IIEF score of case group was significantly lower than control group (IIEF: 17.2 5.5 vs. 14.7 5.3; P<0.001). Additionally, ED severity was significantly greater in case group (no, mild, mild to moderate, moderate, and severe ED: 27.5%, 30.2%, 24.6%, 13.1%, and 4.7% in control group, 10.7%, 27.0%, 33.0%, 18.9%, and 10.4% in case group; P<0.001). Finally, the rate of moderate to severe ED was significantly higher in case group (17.8% vs. 29.3%; P<0.001). CONCLUSIONS: Presence of moderate to severe prostatitislike symptom was significantly and independently correlated with ED.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
泌尿生殖道感染/炎症/囊肿性疾病
简介和目的:众所周知,慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)与勃起功能障碍(ED)密切相关。然而,相关研究并不充分,结果也不一致。我们采用倾向得分匹配法评估了慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)与勃起功能障碍(ED)之间的关系。方法:我们分析了 2011 年至 2013 年期间参加健康体检的 8727 名 40 多岁和 50 多岁男性的数据。本研究采用了美国国立卫生研究院-慢性前列腺炎症状指数(NIH-CPSI)、国际勃起功能指数-5(IIEF)、早泄诊断工具(PEDT)、睾酮、基础血液化学和代谢综合征(MetS)评估。如果受访者表示没有会阴或射精疼痛,或者根据之前的研究,NIH-CPSI 疼痛评分为 7 分,则症状被归类为 "无"。其中 7181 人组成了倾向得分匹配队列,包括 597 名有中度至重度前列腺炎样症状的男性(病例)和 6584 名没有前列腺炎样症状的男性(对照组),但最终倾向得分匹配的对照组和病例组比例为 1:1(对照组 597 名男性,病例组 597 名男性)。结果:倾向得分匹配后,在倾向得分匹配前有显著差异的年龄和 PEDT 变量分布均匀,组间无显著差异(表 1)。匹配后,病例组的 IIEF 平均得分明显低于对照组(IIEF:17.2 5.5 vs. 14.7 5.3;P<0.001)。此外,病例组的 ED 严重程度明显高于对照组(无、轻度、轻中度、中度和重度 ED:对照组分别为 27.5%、30.2%、24.6%、13.1% 和 4.7%,病例组分别为 10.7%、27.0%、33.0%、18.9% 和 10.4%;P<0.001)。最后,病例组的中度至重度 ED 发生率明显更高(17.8% 对 29.3%;P<0.001)。结论:中重度前列腺炎样症状的存在与 ED 有明显的独立相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION). Reply: Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 COURAGE Trial. Reviewer of the Month: Geoffrey Sonn. Comparative Analysis of Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic Assisted Simple Prostatectomy (RASP) in BPH Management: A Systematic Review and Meta-Analysis. Clinical Factors Associated with Suspicious 18F-DCFPyL PSMA PET Activity in Patients Initially Managed with Radical Prostatectomy including PSA <0.5 ng/mL.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1